Towards Healthcare
Life Science CDMO Market North America Emerges as Fastest-Growing Region

Life Science CDMO Market Growth 2025 to 2034 AI Integration, Biologics Surge & Global Partnerships Fuel Expansion

The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approaches, governing water wastage, and dedicated production. North America is dominant as it is the global leader in contract development and manufacturing, and presence of huge clinical trial infrastructure.

Content

  • Last Updated: 25 July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Global CDMO market in life sciences set to grow rapidly through 2034 amid rising sector demand.

North America is currently leading the life science CDMO market due to strong pharmaceutical and biotechnology industries.

The life science CDMO market includes five segments such as by service type, by phase, by customer type, by molecule type, and by region.

Key trends include the rise of advanced therapeutics and personalized medicine, and technological advancements.

A contract development and manufacturing organization (CDMO) is an outsourcing agency for pharmaceutical and life sciences industries specializing in the precise and delicate process of creating and bulk-producing life-changing and lifesaving drugs.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions